Figure 3B contrasts two cases of the KM analysis performed on the breast cancer cohort (BRCA) with two different pathway scoring methods obtained for the Th1 Differential pathway, one using only the upstream of TBX21 signals (referred to as the “R-score”) and the other using TBX21 and its identified downstream target genes (referred to as the “M-score”). This evidence concerns the gene TBX21 and breast carcinoma.